According to Accelerate Diagnostics's latest financial reports and stock price the company's current Operating Margin is -659.11%. At the end of 2021 the company had an Operating Margin of -659.12%.
Year | Operating Margin | Change |
---|---|---|
2021 | -659.12% | -5.9% |
2020 | -700.43% | -22.86% |
2019 | -907.99% | -41.57% |
2018 | -1,554.06% | 2.17% |
2017 | -1,521.07% | -94.34% |
2016 | -26,872.76% | -13.18% |
2015 | -30,951.02% | 20.03% |
2014 | -25,786.89% | -18.52% |
2013 | -31,649.21% | 1306.37% |
2012 | -2,250.42% | 6062.54% |
2011 | -36.52% | -234.04% |
2010 | 27.24% | -150.94% |
2009 | -53.48% | -84.87% |
2008 | -353.37% | -66.37% |
2007 | -1,050.75% | -26.25% |
2006 | -1,424.83% | 242.18% |
2005 | -416.40% | -70.93% |
2004 | -1,432.23% | 773.11% |
2003 | -164.04% | 49.25% |
2002 | -109.91% | -49.57% |
2001 | -217.95% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 14.17% | -102.15% | ๐บ๐ธ USA |
Becton Dickinson BDX | 9.46% | -101.44% | ๐บ๐ธ USA |
PerkinElmer
PKI | 14.13% | -102.14% | ๐บ๐ธ USA |
Bruker BRKR | 18.11% | -102.75% | ๐บ๐ธ USA |
NanoString Technologies NSTG | -116.24% | -82.36% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | -19.26% | -97.08% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.